MedTrace Logo

Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers

NCT01800500 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2022-09-13

No results posted yet for this study

Summary

This randomized clinical trial studies interest in smokeless tobacco product as a substitution for cigarettes in current smokers. Use of smokeless tobacco products may help people stop smoking. Measuring use of other sources of nicotine for cigarettes under a variety of different conditions may help determine whether and how much smokers are willing to use substitutions

Conditions

  • Tobacco Use Disorder

Interventions

BEHAVIORAL

smoking cessation intervention

Purchase ST products using a fixed rate of product prices

BEHAVIORAL

smoking cessation intervention

Purchase ST products using escalating product prices

OTHER

questionnaire administration

Ancillary studies

OTHER

quality-of-life assessment

Ancillary studies

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

ecigarettes

Purchase ST products using escalating product prices nicotine replacement therapy

OTHER

ecigarettes

Purchase ST products using a fixed rate of product prices nicotine replacement therapy

Sponsors & Collaborators

  • Roswell Park Cancer Institute

    lead OTHER

Principal Investigators

  • Martin Mahoney · Roswell Park Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2015-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01800500 on ClinicalTrials.gov